Location History:
- Vieques, PR (US) (2020)
- Madison, CT (US) (2005 - 2021)
Company Filing History:
22 out of 3,685 
2 out of 41 Years Active: 2005-2021
Title: Katharine A Grant-Young: Innovator in Immunomodulation
Introduction
Katharine A Grant-Young, based in Madison, Connecticut, is a prolific inventor with a remarkable portfolio of 24 patents. Her significant contributions to the field of immunomodulation highlight her role in advancing pharmaceutical science. With a strong focus on developing compounds beneficial for treating various diseases, her work has garnered attention and recognition within the scientific community.
Latest Patents
One of her notable recent patents relates to "Compounds useful as immunomodulators." This disclosure encompasses innovative compounds and their corresponding pharmaceutical compositions that are designed to aid in the treatment of diseases, including cancer and infectious diseases. The compounds developed through her research are part of a growing field aimed at improving immune responses in patients, showcasing her commitment to addressing significant health challenges.
Career Highlights
Throughout her career, Katharine has worked with renowned companies, including Bristol-Myers Squibb Company. Her experience in such prominent institutions has provided her with the platform to explore and develop cutting-edge innovations in the pharmaceutical sector. She has made considerable strides in her field, with a focus on creating effective therapies that could change the lives of many patients.
Collaborations
In her professional journey, Katharine has collaborated with esteemed coworkers such as Kap-Sun Yeung and John F Kadow. These partnerships have fostered a rich exchange of ideas and expertise, enhancing the quality and impact of her work in immunomodulation and other related fields.
Conclusion
Katharine A Grant-Young's extensive patent portfolio and her dedication to research mark her as a prominent figure in the realm of innovations and inventions. Her ongoing work with immunomodulators and collaborations with fellow innovators further cements her role as a vital contributor to the advancement of pharmaceutical sciences. As she continues to explore novel compounds, her influence is sure to resonate across the industry, paving the way for future breakthroughs in medical treatments.